Aquestive Therapeutics NDCs and Package Codes
This page lists NDC package records associated with labeler code 10094 (Aquestive Therapeutics) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
12
Package NDCs
6
Products
6
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
1
Dosage forms
3
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 6 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| ondansetron oral 4 mg/1 FILM | 10094-0604-01 | — | On market | View → |
| ondansetron oral film 8 mg/1 FILM | 10094-0608-01 | — | On market | View → |
| Riluzole Oral 50 mg/1 FILM | 10094-0355-01 | — | On market | View → |
| SYMPAZAN clobazam 20 mg/1 FILM | 10094-0220-60 | $65.428 /unit · NADAC | On market | View → |
| SYMPAZAN clobazam 5 mg/1 FILM | 10094-0205-60 | $16.403 /unit · NADAC | On market | View → |
| SYMPAZAN clobazam 10 mg/1 FILM | 10094-0210-60 | $32.758 /unit · NADAC | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.